Systematic review of 25 RCTs (23 meta-analysed; 4,070 participants) in paediatric epilepsy: levetiracetam vs placebo raised seizure freedom (RD 11.0%) but showed no overall advantage vs active antiseizure drugs (RD -2.4%, 95% CI -5.6% to 0.7%).
Meta-analysisn = 4,070
Balestrini et al. Efficacy of Levetiracetam in Patients With Pediatric Epilepsy: A Systematic Review and Meta-Analysis